Skip to content
10-K

Annual Report

CEREVEL THERAPEUTICS HOLDINGS, INC.

0000950170-24-021078

← back to feed
Filed
Feb 27, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 15, 2024 181.58M sh
Shares Diluted FY 2023 · Dec 31, 2023 162.06M sh
Shares Diluted FY 2023 · Dec 31, 2022 151.27M sh
Shares Diluted FY 2023 · Dec 31, 2021 136.58M sh
Capex FY 2023 · Dec 31, 2023 $3.81M
Capex FY 2023 · Dec 31, 2022 $3.95M
Capex FY 2023 · Dec 31, 2021 $10.5M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$342.3M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$293.19M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$178.55M
Long Term Debt FY 2023 · Dec 31, 2023 $379.5M
Cash And Equivalents FY 2023 · Dec 31, 2023 $416.47M
Cash And Equivalents FY 2023 · Dec 31, 2022 $136.52M
Stockholders Equity FY 2023 · Dec 31, 2023 $673.75M
Stockholders Equity FY 2023 · Dec 31, 2022 $521.24M
Stockholders Equity FY 2023 · Dec 31, 2021 $578.73M
Stockholders Equity FY 2023 · Dec 31, 2020 $384.52M
Current Liabilities FY 2023 · Dec 31, 2023 $92.18M
Current Liabilities FY 2023 · Dec 31, 2022 $72.56M
Total Liabilities FY 2023 · Dec 31, 2023 $569.55M
Total Liabilities FY 2023 · Dec 31, 2022 $496.58M
Current Assets FY 2023 · Dec 31, 2023 $1.01B
Current Assets FY 2023 · Dec 31, 2022 $905.65M
Total Assets FY 2023 · Dec 31, 2023 $1.24B
Total Assets FY 2023 · Dec 31, 2022 $1.02B
Eps Diluted FY 2023 · Dec 31, 2023 −$2.67
Eps Diluted FY 2023 · Dec 31, 2022 −$2.32
Eps Diluted FY 2023 · Dec 31, 2021 −$1.65
Eps Basic FY 2023 · Dec 31, 2023 −$2.67
Eps Basic FY 2023 · Dec 31, 2022 −$2.32
Eps Basic FY 2023 · Dec 31, 2021 −$1.65
Sga Expense FY 2023 · Dec 31, 2023 $112.62M
Sga Expense FY 2023 · Dec 31, 2022 $87.59M
Sga Expense FY 2023 · Dec 31, 2021 $58.24M
Rd Expense FY 2023 · Dec 31, 2023 $334.64M
Rd Expense FY 2023 · Dec 31, 2022 $280.26M
Rd Expense FY 2023 · Dec 31, 2021 $161.86M
Net Income FY 2023 · Dec 31, 2023 −$432.84M
Net Income FY 2023 · Dec 31, 2022 −$351.51M
Net Income FY 2023 · Dec 31, 2021 −$225.33M
Operating Income FY 2023 · Dec 31, 2023 −$447.27M
Operating Income FY 2023 · Dec 31, 2022 −$367.85M
Operating Income FY 2023 · Dec 31, 2021 −$220.1M
Revenue FY 2023 · Dec 31, 2023 $0